Determinants of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy: findings from a national population survey of U.S. adults.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
25 05 2022
Historique:
received: 16 11 2021
accepted: 17 05 2022
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

The enduring presence of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy is an ongoing impediment to the global response effort to the current pandemic. This study seeks to identify determinants of skepticism and vaccine hesitancy in U.S. adults. Data are from the Values and Beliefs of the American Public Survey, conducted in 2021 by the Gallup Organization in conjunction with Baylor University. The survey used stratified random probability sampling of the U.S. adult population (N = 1222). Outcome measures were respective single items assessing COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy. Exposure variables included political, religious, and sociodemographic indicators, and moderators assessed personal history of COVID-19 and losing a relative or close friend to COVID-19. Skepticism and vaccine hesitancy were strongly associated with conservative and Republican political preference and conservative religious beliefs, and less so with socioeconomic status. Personal experience with COVID-19 did not mitigate the effect of politics on skepticism and barely reduced the odds for hesitancy. Results confirm that attitudes toward COVID-19 are politically and religiously conditioned, and are especially a product of conservative political preference. Skepticism about COVID-19 and hesitancy regarding SARS-CoV-2 vaccination are highest among the political and religious right. Efforts to increase immunization through public education may be inadequate; resistance appears ideological. Other solutions may need to be considered, which risk widespread pushback both politically and religiously motivated.

Sections du résumé

BACKGROUND
The enduring presence of COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy is an ongoing impediment to the global response effort to the current pandemic. This study seeks to identify determinants of skepticism and vaccine hesitancy in U.S. adults.
METHODS
Data are from the Values and Beliefs of the American Public Survey, conducted in 2021 by the Gallup Organization in conjunction with Baylor University. The survey used stratified random probability sampling of the U.S. adult population (N = 1222). Outcome measures were respective single items assessing COVID-19 skepticism and SARS-CoV-2 vaccine hesitancy. Exposure variables included political, religious, and sociodemographic indicators, and moderators assessed personal history of COVID-19 and losing a relative or close friend to COVID-19.
RESULTS
Skepticism and vaccine hesitancy were strongly associated with conservative and Republican political preference and conservative religious beliefs, and less so with socioeconomic status. Personal experience with COVID-19 did not mitigate the effect of politics on skepticism and barely reduced the odds for hesitancy. Results confirm that attitudes toward COVID-19 are politically and religiously conditioned, and are especially a product of conservative political preference.
CONCLUSION
Skepticism about COVID-19 and hesitancy regarding SARS-CoV-2 vaccination are highest among the political and religious right. Efforts to increase immunization through public education may be inadequate; resistance appears ideological. Other solutions may need to be considered, which risk widespread pushback both politically and religiously motivated.

Identifiants

pubmed: 35614396
doi: 10.1186/s12889-022-13477-2
pii: 10.1186/s12889-022-13477-2
pmc: PMC9132354
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1047

Informations de copyright

© 2022. The Author(s).

Références

Psychol Health Med. 2021 Aug 18;:1-11
pubmed: 34407721
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Hum Vaccin Immunother. 2021 Aug 3;17(8):2373-2377
pubmed: 33764283
J Community Health. 2021 Dec;46(6):1161-1169
pubmed: 33999317
Polit Q. 2022 Apr-Jun;93(2):347-351
pubmed: 35600736
PLoS Med. 2018 Jul 6;15(7):e1002616
pubmed: 29979682
Anthropol Med. 2021 Mar;28(1):122-139
pubmed: 33233926
Soc Sci Med. 2020 Oct;263:113356
pubmed: 32967786
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Can Vet J. 2021 Mar;62(3):247-252
pubmed: 33692579
S Afr Med J. 2021 Aug 05;111(9):852-856
pubmed: 34949249
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10321-4
pubmed: 26240325
Prog Mol Biol Transl Sci. 2022;188(1):81-100
pubmed: 35168748
Public Health Rep. 2022 Jan-Feb;137(1):11-16
pubmed: 34694939
Vaccine. 2021 Jun 8;39(25):3333-3337
pubmed: 34020814
Clin Infect Dis. 2022 Apr 28;74(8):1429-1441
pubmed: 34272559
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
Psychol Mark. 2022 Apr;39(4):741-754
pubmed: 35465079
BMC Public Health. 2021 Apr 30;21(1):832
pubmed: 33931055
Environ Res. 2022 Apr 15;206:112240
pubmed: 34688639
Adv Ther. 2020 Nov;37(11):4481-4490
pubmed: 32965654
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Ann Transl Med. 2021 Apr;9(7):585
pubmed: 33987283
PLoS One. 2021 Jul 13;16(7):e0254511
pubmed: 34255781
Microbes Infect. 2020 May - Jun;22(4-5):162-164
pubmed: 32442682
Nat Rev Immunol. 2022 Jun;22(6):333-334
pubmed: 35440758
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Nat Rev Immunol. 2020 Oct;20(10):583-584
pubmed: 32908300
Ann Pharmacother. 2011 Oct;45(10):1302-4
pubmed: 21917556
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
Curr Opin Immunol. 2021 Aug;71:62-68
pubmed: 34118728
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Public Health. 2021 May;194:245-251
pubmed: 33965796

Auteurs

Jeff Levin (J)

Baylor University, One Bear Place # 97236, Waco, TX, 76798, USA. jeff_levin@baylor.edu.

Matt Bradshaw (M)

Baylor University, One Bear Place # 97236, Waco, TX, 76798, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH